Scotland · NHS Scotland MSAN
Memantine (Valios®) 10mg and 20mg orodispersible tablets sugar free
MSAN(2024)30 · Level 2 · issued 30 May 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Valios® 10mg and 20mg orodispersible tablets are out of stock until late August 2024. | Out of stock | late August 2024 |
| 2. Valios® 5mg orodispersible tablets remain available and can support a partial increase in | Available — partial uplift only | — |
| 3. Memantine 10mg/ml oral solution and Ebixa® 5mg pump oral solution remain available and can | Available | — |
| orodispersible tablets to make up the dose, which can support a partial increase in demand; | Available — partial uplift only | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:30
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
93f5aeab7dcadfa1c8081122e6daf542639e3258814539251238b48b5b392487sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-30.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.